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Abstract
Background: Most arthropod-borne viruses (arboviruses) are RNA viruses, which are maintained in nature by replication
cycles that alternate between arthropod and vertebrate hosts. Arboviruses appear to experience lower rates of evolution
than RNA viruses that replicate in a single host. This genetic stability is assumed to result from a fitness trade-off imposed by
host alternation, which constrains arbovirus genome evolution. To test this hypothesis, we used Rift Valley fever virus
(RVFV), an arbovirus that can be transmitted either directly (between vertebrates during the manipulation of infected
tissues, and between mosquitoes by vertical transmission) or indirectly (from one vertebrate to another by mosquito-borne
transmission).
Methodology/Principal Findings: RVFV was serially passaged in BHK21 (hamster) or Aag2 (Aedes aegypti) cells, or in
alternation between the two cell types. After 30 passages, these single host-passaged viruses lost their virulence and
induced protective effects against a challenge with a virulent virus. Large deletions in the NSs gene that encodes the
virulence factor were detectable from the 15
th serial passage onwards in BHK21 cells and from the 10
th passage in Aag2
cells. The phosphoprotein NSs is not essential to viral replication allowing clones carrying deletions in NSs to predominate as
they replicate slightly more rapidly. No genetic changes were found in viruses that were passaged alternately between
arthropod and vertebrate cells. Furthermore, alternating passaged viruses presenting complete NSs gene remained virulent
after 30 passages.
Conclusions/Significance: Our results strongly support the view that alternating replication is necessary to maintain the
virulence factor carried by the NSs phosphoprotein.
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Introduction
Most arthropod-borne viruses (arboviruses) are RNA viruses,
although they use a variety of strategies to ensure their replication
and transmission. The feature that best distinguishes RNA
genomes from DNA ones is the high mutation rate of the former
during replication. Misincorporation errors during replication
have been estimated to occur within the range of 10
23–10
25
substitutions per nucleotide and per round of copying [1]. The
main factor contributing to such high mutation rates is a lack of
proof-reading repair activities that is associated with RNA
replicases [2]. Another source of mutations results from the
spontaneous deamination of Cytidine residues to Uracil. In DNA
genomes, this reaction is repaired by a Uracil-glycosylase, but this
cannot function on an RNA template [3]. The resulting complex
mixtures of closely related RNA genomes are termed quasispecies
[4,5] whose existence allow RNA viruses to adapt rapidly to
fluctuating environments [6,7]. Indeed, mutation rates per
nucleotide site of around 10
24 mean that for a 10 kb genome,
an average of one mutation is incorporated each time the genome
is copied, and it is this, together with short replication times and
large population sizes, that ensure the existence of the quasispecies
genome pool.
However, sequence comparisons reveal that RNA arboviruses
are relatively stable in nature, suggesting that the alternating host
cycle (between vertebrate and invertebrate hosts) constrains viral
evolution by a strong conservative sequence selection. This
sequence stability may result from the requirements for replication
in two separate hosts that present conflicting niches for replication
and adaptation [8]. Furthermore, low rates of evolution do not
necessarily reflect the adaptive compromise of a virus to the
alternating host cycle [9], but could be principally related to other
biological constraints including the need to maintain virulence
[10,11]. Effectively, more virulent viral strains are generally at a
competitive advantage in mixed-strain infections [12]. Virulence
can be considered as a consequence of virus efforts to maximize its
www.plosntds.org 1 May 2011 | Volume 5 | Issue 5 | e1156fitness: the virus must replicate extensively in a host to ensure its
transmission to the next host. However, viral replication damages
host tissues, leading to host death, which can be considered as
seriously deleterious for virus survival [13,14]. Alternation may
play a significant role in maintaining the genetic stability of
arboviruses; setting aside one or several selective filters may lead to
accelerate evolution. For such, we used a cell culture system for
these studies, as in vitro systems are convenient to investigate the
evolution of arboviruses.
Contrary to most arboviruses, Rift Valley fever virus (RVFV), a
member of the Phlebovirus genus within the Bunyaviridae family can
be transmitted through direct contact with body fluids or aborted
fetuses. It constitutes an interesting model to study host alternating
cycling as cause of genetic stability of arboviruses in nature. RVFV
is a tri-segmented negative-stranded RNA virus composed of the L
segment that codes for the RNA-dependent RNA polymerase, the
M segment that codes for the GN and GC glycoprotein precursor,
and the S segment that has an ambisense strategy, coding for the N
nucleoprotein and the NSs phosphoprotein [15]. The NSs
phosphoprotein plays a key role in RVFV pathogenesis in the
mammalian host. A natural isolate defective for the NSs protein
(Clone 13; [16]), was found to be avirulent for mice [17] and to
induce an interferon response in mammalian cells, in contrast to
virulent RVFV strains [18].
Here, we present results showing that genetic material non-
essential to viral replication such as the phosphoprotein NSs is
rapidly eliminated leading to the loss of virulence.
Materials and Methods
Ethics Statement
The Institut Pasteur animal facility has received accreditation
from the French Ministry of Agriculture to perform experiments
on live mice in appliance of the French and European regulations
on care and protection of the Laboratory Animals. This study was
approved by the relative IACUC at the Institut Pasteur.
Cell cultures
We used two cell lines: a mammalian cell line derived from
hamster kidney (BHK21) and an insect cell line derived from Aedes
aegypti larvae (Aag2). BHK21 cells defective in IFN-a/b signaling
were grown at 37uC with 5% CO2 in Glasgow’s minimal essential
medium (G-MEM) containing 5% fetal bovine serum (FBS), 1000
units/mL penicillin, 1 mg/mL streptomycin, tryptose phosphate
broth 16 and HEPES 0.01M. Monolayer cultures of Aag2 cells
were grown at 28uC in Schneider Drosophila medium supple-
mented with 10% heat-inactivated FBS, L-Glutamine 0.46, 1000
units/mL penicillin and 1 mg/mL streptomycin.
Virus strains
The parental P strain was derived from the ZH548 strain
originally isolated in 1977 from a human case in Egypt [19] and
passaged three times in Vero cells. The virulence of this strain is
relatedto the phosphoproteinNSs, whichis responsible fora general
inhibition of cellular RNA synthesis by interacting with the p44
subunit of the TFIIH transcription factor [20]. Furthermore, NSs
strongly antagonizes IFN-ß production [17,18,21,22]. The titer of
the frozen virus stock was 10
6.8 PFU (plaque forming unit)/mL.
Moreover, the other virus strains were produced at high titers:
Z30Alt at 10
8.3 PFU/mL, Z30B at 10
7.6 PFU/mL and Z30A at
10
8.5 PFU/mL. Viral titers were estimated by serial 10-fold
dilutions on Vero cells.
In addition, biological clones Z30AC and Z30BC were
produced by plaque purification and amplification in Vero cells
from the 30
th serial passage of parental P strain in Aag2 cells
(Z30A strain) and BHK21 cells (Z30B strain), respectively. Briefly,
six-well plates containing confluent monolayers of Vero cells were
infected with serial 10-fold dilutions of virus. Cells were incubated
for five days under an overlay consisting of Dulbecco’s MEM
(DMEM), 2% FBS, antibiotics and 1% agarose at 37uC. The lytic
plaques were localized and removed by suction using a pipette.
Each agarose plug that contained an individual clone was
dissolved overnight at +4uC in DMEM supplemented with 10%
FBS before being re-amplified in BHK21 or Aag2 cells,
respectively [23]. Both clones were produced at high titers:
10
8.8 PFU/mL for Z30BC and 10
8.7 PFU/mL for Z30AC.
Serial/alternating passaging of virus
The parental P strain virus was subjected to 30 serial passages in
BHK21 cells or Aag2 cells, or 30 passages that alternated between
BHK21 and Aag2 cells (i.e. 15 passages in BHK21 cells and 15
passages in Aag2 cells), at a multiplicity of infection (MOI) of
0.1 PFU/cell. Virus was adsorbed for 1 hr onto confluent cell
monolayers prepared in plastic flasks of 25 cm
2,a t2 8 uC for Aag2
and at 37uC for BHK21. After adsorption, the inoculum was
removed, cells were washed with medium, 13 mL of maintenance
medium (with 2% FBS) was added and cells were incubated at the
appropriate temperature. Cell supernatants were harvested when
titers reached a plateau (Figure S1): at 48 hr p.i. for BHK21 and
96 hr p.i. for Aag2 cells. At each passage, supernatants were
harvested and stored in aliquots at 280uC for titration on Vero
cells.
Viral replication curve analysis
Plastic flasks of 75 cm
2 containing confluent cell monolayers
(Aag2 or BHK21) were infected at a MOI of 0.1 PFU/cell as
described above. The supernatant from a flask was harvested every
2 hr from 0 to 12 hr p.i. and every 24 hr from 0 to 120 hr p.i., and
titrated on Vero cells by serial 10-fold dilution [24].
RT-PCR amplification and sequencing
Total RNA was extracted from aliquots of supernatants
(100 mL) using the Nucleospin RNA II kit (Macherey-Nagel)
Author Summary
Arthropod-borne viruses are transmitted among verte-
brate hosts by insect vectors. Unusually, Rift Valley fever
virus (RVFV) can also be transmitted by direct contacts of
animals/humans with infectious tissues. What are the
molecular mechanisms and evolutionary events leading to
adopt one mode of transmission rather than the other?
Viral replication is implied to be different in a vertebrate
host and an invertebrate host. The alternating host cycle
tends to limit virus evolution by adopting a compromise
fitness level for replication in both hosts. To test this
hypothesis, we used a cell culture model system to study
the evolution of RVFV. We found that freeing RVFV from
alternating replication in mammalian and mosquito cells
led to large deletions in the NSs gene carrying the
virulence factor. Resulting NSs-truncated viruses were able
to protect mice from a challenge with a virulent RVFV.
Thus, in nature, virulence is likely maintained by contin-
uous alternating passages between vertebrates and
insects. Thereby, depending on the mode of transmission
adopted, the evolution of RVFV will be of major
importance to predict the outcome of outbreaks.
Genome Stability of RVFV
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targeting the NSs gene was conducted using the Titan One Tube
RT-PCR kit (Roche Applied Science) following the manufactur-
er’s recommendations. Primers were selected in the NSs gene that
lies within the S genome segment. The amplification program was
performed as follows: reverse transcription at 50uC for 30 min, an
inactivation of RT enzyme step at 95uC for 3 min, followed by 35
cycles of 95uC3 0s ,5 1 uC3 0s ,7 2 uC 1 min, and a final step at
72uC for 5 min. The size of the PCR product was 781 bp. PCR
products were excised from the gel and eluted using the QIAquick
Gel Extraction Kit (Qiagen) as specified by the manufacturer. The
recovered DNA was cloned into the Topo TA vector and
transformed into Top10 competent cells according to the
manufacturer’s protocol. Colonies were screened by direct PCR,
using insert-specific primers. Plasmid DNA was purified using a
QIAprep Spin Miniprep kit (Qiagen), as specified by the
manufacturer. Sequencing was carried out using virus-specific
primers. In addition, the three segments (S, M and L) of the
parental P strain and the selected strains (Z30Alt, Z30B and Z30A)
were completely sequenced. For each segment, primers were
designed (based on the nucleotide sequence of the reference strain
ZH548) in order to obtain around 700 pb RT-PCR amplicons
with an overlap of around 100 pb along the entire segment (Table
S1). Amplicons were obtained using SuperScript One-Step RT-
PCR with platinium Taq (Invitrogen) following the manufacturer’s
recommendations. The amplification program was performed as
follows: reverse transcription at 50uC for 30 min, an inactivation
of RT enzyme step at 94uC for 2 min, followed by 35 cycles of
94uC1 5s ,5 0 uC3 0s ,7 2 uC 1 min 30, and a final step at 72uC for
10 min. The obtained fragments were purified by ultrafiltration
(Millipore). Sequencing reactions were performed using the
BigDye Terminator v1.1 cycle sequencing kit (Applied Biosystems)
and purified by ethanol precipitation. Sequence chromatograms
from both strands were obtained on automated sequence analyzer
ABI3730XL (Applied Biosystems). For sequence analysis, contig
assembly was performed using the software BioNumerics version
5.1 (Applied-Maths, Sint-Martens-Latem, Belgium). Sequence
alignments and computation of substitution tables were also
performed using the BioNumerics software. For phylogenetic
analysis, maximum-likelihood trees were constructed using MEGA
version 4 [25] with the Kimura-2 parameter for corrections of
multiple substitutions. Reliability of nodes was assessed by
boostrap resampling with 1,000 replicates.
Mice infections
The pathogenicity of the parental P strain, and the selected
strains, Z30Alt, Z30B, Z30A, Z30BC or Z30AC, was assayed in 4-
to 5-week-old female Swiss mice (OF-1; Charles River, France) by
inoculating 10
4 PFU intraperitoneally into each mouse. The
control was inoculated with DMEM supplemented with 10%
FBS. Mice surviving at the end of the observation period were bled
and their sera tested for IgG by enzyme-linked immunosorbent
assay (ELISA) [26]. Two experiments were carried out. In the first,
each batch of five mice was infected with a different virus strain: P,
Z30Alt, Z30B, Z30A, Z30BC or Z30AC. One batch was used as
the control. Mice were kept under observation for 21 days post-
inoculation or until death occurred. In the second experiment, we
aimed to detect the IgG protective capacity induced by selected
clones in inoculated mice. Batches of 12 mice were inoculated with
the clones Z30BC and Z30AC, and one batch was used as control.
At day 14 post-inoculation, one half of surviving mice from each
batch was challenged with 10
4 PFU of the parental P strain and
the other half was inoculated with DMEM. Mice were then
observed for 21 days after challenge.
Results
Figure 1 describes the strategy adopted to test the hypothesis
that an alternating host cycle constrains the evolution of RVFV.
Adaptation to a single cell type results in higher
replication rates in the same cell type
To compare the replication of selected RVFV strains (Z30B,
Z30A, Z30BC, Z30AC) to the parental P strain, replication
kinetics were determined in BHK21 cells and in Aag2 cells. When
examining replication rates in BHK21 cells (Figure 2A), all strains
gave similar patterns of viral growth, with an initial exponential
growth phase until 24 hr post-infection (p.i.) followed by a plateau.
However, the Z30BC clone exhibited higher titers than other virus
strains, almost 1 log10 PFU/mL higher from 6 hr p.i. until 72 hr
p.i. Furthermore, viral replication was detectable two hours earlier
for Z30BC than for the other four strains tested. This strain
reached a maximum titer of around 9 log10 PFU/mL from 24 hr
p.i. onwards. These results suggest that the Z30BC strain was
better adapted to BHK21 cells than other strains were, and that
the 30
th passage in BHK21 cells (Z30B) from which Z30BC was
derived encompassed a mixture of different viral clones with
variable capacities to replicate in BHK21 cells. When replication
rates in Aag2 cells were analyzed (Figure 2B), differences in titers
were clear-cut from 24 hr p.i. onwards. Effectively, Z30A and the
Z30AC clone derived from this strain replicated to higher titers
than the other three strains tested: ,4 log10 PFU/mL higher at
48 hr p.i. and ,2 log10 PFU/mL higher at 96 hr p.i. Moreover,
replication of Z30A and Z30AC was detectable 24 hr earlier than
that of the other strains, suggesting their better adaptation to Aag2
cells. In summary, the two selected clones that resulted from serial
passages in either BHK21 or Aag2 cells exhibited an increased
replication capacity in the corresponding cell type.
Viral strains isolated after passaging in a single cell type
induce attenuation in mice
We inoculated four-week-old mice intraperitoneally with
10
4 PFU of one of six viral strains to evaluate their virulence.
Strains tested were: P (the parental strain), Z30Alt (isolated at the
30
th alternating passage in BHK21 and Aag2 cells), Z30B (pool
harvest at the 30
th serial passage in BHK21 cells), Z30A (pool
harvest at the 30
th serial passage in Aag2 cells), Z30BC (clone
selected at the 30
th serial passage in BHK21 cells) and Z30AC
(clone selected at the 30
th serial passage in Aag2 cells). Mouse
survival rates were recorded over 21 days post-inoculation
(Figure 3A). The control, inoculated with Dulbecco’s MEM
(DMEM) medium, survived 21 days. All batches of mice
inoculated with a given viral strain also survived, except for those
inoculated with the parental P strain and the 30
th alternating
passage strain (Figure 3A). All mice inoculated with P died before
day 7 post-inoculation, and 4 of 5 treated with Z30Alt died before
day 9 post-inoculation. Thus, the 30
th alternating passage strain
behaved roughly like the parental P strain after 30 passages. All
surviving mice were tested for the presence of IgG against RVFV
at day 21 post-inoculation, and showed positive compared to the
IgG level in non-infected mice (Table S2).
To test the protective effect of infection by clones Z30BC or
Z30AC against infection pool harvest with the parental P strain,
further batches of mice were first inoculated with the Z30BC or
Z30AC clones and then challenged 14 days later by inoculation
with the parental P strain. Mortality rates were scored up to 21
days after challenge (Figure 3B). Before challenge, all mice had
survived. The control mice started to die five days after challenge,
and no controls survived beyond 9 days after challenge. Batches of
Genome Stability of RVFV
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days. When mice previously inoculated with the Z30BC clone
were challenged with the P strain, all mice survived 21 days after
challenge. This suggests protection by the Z30BC clone selected in
BHK21 cells. Mice sera were all IgG positive (Table S3). In
batches of mice first inoculated with the clone Z30AC, one among
6 mice died 8 days after challenge with the parental P strain. The
five others survived 21 days after challenge. The sera of the
surviving mice were IgG positive (Table S3), suggesting that
primary inoculation with the Z30AC clone selected in Aag2 cells
could protect mice against a secondary inoculation with the
parental P strain.
NSs undergoes large deletions during passages through
a single cell type
As the phosphoprotein NSs has been shown to be responsible for
virulence, we used RT-PCR amplification to monitor the NSs gene
upon serial or alternating passages through BHK21 and Aag2
cells. Amplification of the parental P strain NSs gene generated an
amplicon of ,780 bp (Figure 4A). Upon serial passage in BHK21
cells, PCR products from the 10
th,2 0
th and 30
th passage exhibited
different sized amplicons, with a predominant band at 700–800 bp
at the 10
th and 20
th passages and a band at 500–600 bp at the 30
th
passage (Figure 4A). When examining the RT-PCR profiles for
different serial passages in BHK21 cells in detail, it could be seen
that the 500–600 bp band was detectable from the 15
th passage,
reaching maximum expression from the 25
th passage onwards,
concomitant with a decrease in the expression of 700–800 bp
bands (Figure 4B). The shortening of the NSs gene coincided with
the loss of cellular lysis in BHK21 cells, evident by the 30
th
passage. Upon serial passages in Aag2 cells, a band of the expected
size corresponding to the NSs gene was found at the 10
th passage,
whereas a smaller band of 500–600 bp was detected at the 20
th
and 30
th passage (Figure 4A). This smaller band was actually
found as early as the 11
th passage, and became predominant by
the 21
st passage (Figure 4C), since the 700–800 bp band decreased
in quantity from the 20
th passage. In contrast, when virus was
subjected to alternating passages, only a major band at 700–
800 bp was found, irrespective of passage number (Figure 4A).
To characterize more precisely the molecular events associated
with the emergence of viral variants, clones were analyzed by RT-
PCR and sequencing of the NSs gene. Virus from the 30
th passage
in BHK21 or Aag2 cells showed large deletions in NSs, while
viruses passaged alternately through the two cell types showed no
nucleotide changes, suggesting the maintenance of NSs integrity
during alternating cell-type passages. 48 clones isolated from the
30
th serial passage in BHK21 presented two deletions: (i) a deletion
of 259 nucleotides (nt) at position 124 that leads to a shift in the
NSs open reading frame (ORF), introducing a stop codon at
position 437, and (ii) a smaller deletion of 6 nt at position 650.
Figure 1. Experimental strategy to test RVFV evolution in vitro. The parental P strain virus was subjected to 30 serial passages in BHK21 cells
or Aag2 cells, or 30 passages that alternated between BHK21 and Aag2 cells, using a multiplicity of infection (MOI) of 0.1 PFU/cell. The fitness of P (the
parental strain), Z30Alt (bulk harvest at the 30
th alternating passage in BHK21 and Aag2 cells), Z30B (bulk harvest at the 30
th serial passage in BHK21
cells), Z30A (bulk harvest at the 30
th serial passage in Aag2 cells), Z30BC (a clone isolated after the 30
th serial passage in BHK21 cells) and Z30AC (a
clone isolated after the 30
th serial passage in Aag2 cells) were tested by inoculation into mice. Genetic changes were detected by sequencing the NSs
gene carrying the virulence factor.
doi:10.1371/journal.pntd.0001156.g001
Genome Stability of RVFV
www.plosntds.org 4 May 2011 | Volume 5 | Issue 5 | e1156Figure 2. Replication of RVFV strains in vitro. BHK21 cells (A) and Aag2 cells (B) were infected at a MOI of 0.1 PFU/cell. After 1 hr of absorption,
the inoculum was removed and supernatants were harvested and titrated by serial 10-fold dilutions on Vero cells. The viral strains tested were: P (the
parental strain), Z30B (from the 30
th serial passage in BHK21 cells), Z30A (from the 30
th serial passage in Aag2 cells), Z30BC (a clone selected from the
30
th serial passage in BHK21 cells) and Z30AC (a clone selected from the 30
th serial passage in Aag2 cells).
doi:10.1371/journal.pntd.0001156.g002
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after 30 passages in Aag2 cells presented two deletions in the NSs
gene: (i) a deletion of 73 nt at position 374, inducing a shift in the
ORF with the introduction of a stop codon at position 474, and (ii)
a deletion of 157 nt at position 536. The Z30AC clone thus
presents a 568 nt NSs gene. Figure 5 summarizes the cartography
of the deletions found in the NSs gene of clones Z30BC and
Z30AC compared to the parental P strain. In contrast, Z30Alt
which was isolated from the 30
th alternating passage in BHK21
and Aag2 cells had no deletion in the Nss gene. These results
suggest that all clones containing a shorter NSs gene than the
parent resulted from a single molecular event in both BHK21 and
Aag2 cells; in our experiment, all 48 clones examined from the
30
th serial passage presented the same deletions. To further
explore the molecular features of the parental P strain and the
selected strains (Z30Alt, Z30B and Z30A), the complete
sequencing of the three segments S, M and L was achieved.
Except for the previously described deletions in the NSs gene for
the strains Z30B and Z30A, no other deletions or mutations were
observed in the S segment for the parental P strain, the Z30B and
Figure 3. Survival of mice inoculated with RVFV strains. Mice were observed for 21 days post-inoculation (A) or 36 days after challenge with
the parental P strain given 14 days post-inoculation (B). The first experiment used batches of mice inoculated with 10
4 PFU of a viral strain and kept
for 21 days post-inoculation. The second experiment used batches of mice inoculated with 10
4 PFU of Z30BC or Z30AC. At day 14 post-inoculation,
one half of surviving mice were challenged with 10
4 PFU of P and the other half were inoculated with medium. Mice were then observed for 21 days
after challenge. The control was inoculated with medium before being challenged by 10
4 PFU of P. The viral strains tested were: P (the parental
strain), Z30Alt (from the 30
th alternating passage in BHK21 and Aag2 cells), Z30B (from the 30
th serial passage in BHK21 cells), Z30A (from the 30
th
serial passage in Aag2 cells), Z30BC (a clone selected from the 30
th serial passage in BHK21 cells) and Z30AC (a clone selected from the 30
th serial
passage in Aag2 cells).
doi:10.1371/journal.pntd.0001156.g003
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www.plosntds.org 6 May 2011 | Volume 5 | Issue 5 | e1156Figure 4. Nature of the NSs gene after 10, 20 and 30 passages. (A) Agarose gel electrophoresis showing the NSs gene amplified by RT-PCR.
Details of serial passages on BHK21 cells (B) and Aag2 cells (C) are given. Total RNAs were extracted from supernatants and RT-PCR targeting the NSs
gene was conducted. L: 100-pb ladder; P: parental viral strain; T-: negative control.
doi:10.1371/journal.pntd.0001156.g004
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gene for the Z30Alt strain (Table S4). Concerning the segments M
and L, no deletion event was found for the four strains, and the
phylogenetic analysis (Figure S2) confirmed a cluster in the genetic
lineage A around the reference strain ZH548 originally isolated in
1977 in Egypt [27]. Nevertheless, the segments M and L presented
some mutations, for most non silent, in the three selected strains.
As expected, the segment M was the most variable with a total of
11 amino-acid substitutions compared to the segment L with only
five amino-acid changes (Table S4). To note, the segment M of the
three selected strains have retained the previously described five
in-frame AUG-methionine start codons and the different amino-
acids involved in glycosylation [27].
Discussion
Results presented in this paper support the hypothesis that an
alternating viral cycle comprising of infection of two distinct hosts
constrains the evolution of RVFV. The study model used consisted
of abolishing the alternate host environment using a cell culture
system. Serial passages in a single cell type led to the loss of
virulence. Large deletions were observed in the NSs gene, non-
essential to viral replication. The rapid emergence of NSs-deleted
variants in the course of serial passages is likely to result from a
selective advantage in their replication rates.
After 30 serial passages in either mammalian BHK21 cells
defective in IFN-a/b signaling or mosquito Aag2 cells, single-host
adapted viruses from mosquito cells (Z30A and Z30AC) replicated
better in mosquito cells. These mosquito-cell adapted viruses
reached higher titers (2 log10 PFU/mL higher) than non-adapted
viruses, and their replication was detectable earlier (24 hr earlier).
Interestingly, full adaptation to mammalian cells needed more
passages as shown in the Figure 4B where the deleted variant was
not totally predominant at the 30
th serial passage in BHK21 cells.
Replication patterns of the Z30B strain in mammalian cells were
similar to those of the parental P strain and of viruses that had
bypassed this host. However, the Z30BC clone isolated from the
30
th serial passage in BHK21 cells presented the highest
replication rate in mammalian cells (replication was detectable
2 hr earlier and reached a titer ,2 log10 PFU higher than for
other viruses). This result suggested that a higher number of
passages would favor adaptation to BHK21 cells which are
defective in IFN-a/b signaling. Viral clones from single-cell
passages showed a consistent fitness advantage over the parental
P strain in the cell type used for their selection: the Z30BC clone
exhibited a fitness advantage in BHK21 cells and the Z30AC
clone in Aag2 cells. Thus, our clones isolated from single-host
adapted passages present fitness gains in their specific host, and no
fitness changes in the bypassed host. Similar results have been
obtained for members of various arbovirus families using cell
culture model systems [28–31] or in vivo systems [28,30,32–35].
Surprisingly, when sequencing the NSs gene, that encodes the
virulence factor responsible for a general inhibition of cellular
RNA synthesis and IFN-ß production, we found that single-host
adapted viruses presented large deletions in this gene. Virus
passaged in mammalian BHK21 cells defective in IFN-a/b
signaling had a deletion of 259 nt introducing a stop-codon in
the NSs gene. The resulting protein was shortened to 60 amino-
acids instead of 265. Virus passaged in mosquito Aag2 cells
showed a deletion of 73 nt, again with a stop-codon, causing a
shortening of the NSs protein to 131 amino-acids. These two
distinct deletions in the NSs gene following 30 serial passages in
each cell type suggest that the viral genome may function
differently depending on whether replication is in mammalian or
mosquito cells. Thus, while serial passages of RVFV in a single cell
type selected for a virus with a truncated NSs gene specific to that
cell type, alternating passages did not allow the emergence of
deletions in the NSs gene. Indeed, like the parental P strain, the
30
th alternating passage virus Z30Alt did not present any major
genetic changes in the NSs gene. The fact that the NSs gene is
dispensable in both single host systems suggests that other
mutations are involved in the host adaptation process. Thus, the
different non-synonymous mutations identified in the segments M
and L should be further explored in this context, particularly since
they are mostly specialized depending on host. It is likely that these
kinds of deletion events take place spontaneously during viral
replication and are selected only in the absence of alternation.
Further experiments involving independent serial passages would
permit to evaluate the frequency at which the phenomenon
occurs. Deletions in the NSs gene have been described in a
naturally attenuated RVFV (Clone 13) purified from a nonfatal
human case in the Central African Republic [16]. This strain has a
large internal deletion of 549 nt in the NSs gene (,70% of its
length). Animals can survive high infectious doses of Clone 13, up
to 10
6 PFU, without developing any symptoms. Furthermore,
Clone 13 has been tested as a vaccine candidate in sheep and
cattle that can indeed then elicit a protective response against
challenge with a virulent RVFV strain. When the clones we
obtained after 30 serial passages in a single cell type were
inoculated into mice (at 10
4 PFU), the animals survived for 21
days and developed protective IgG against challenge with a
virulent strain of RVFV. Moreover, most mice inoculated with
Z30Alt (isolated at the 30
th alternating passage) died 2 days later
than did those treated with the parental P strain, and one mouse
Figure 5. Cartography of the NSs gene from the parental P strain and the in vitro selected strains, Z30Alt, Z30BC and Z30AC. Z30BC
and Z30AC were cloned by plaque purification and amplification on Vero cells. Briefly, cells were incubated for five days under an overlay consisting
of DMEM, and the lytic plaques formed were removed individually and dissolved for RNA extraction, RT-PCR and sequencing analysis.
doi:10.1371/journal.pntd.0001156.g005
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outcome of infection is mainly determined by a balance between
the rate of viral replication and the immune response, which
together limit viral spread [36]. This might explain why one of five
mice recovered from infection. Nevertheless, the 30
th alternating
passage virus Z30Alt retained roughly the same level of virulence
as the parental P strain owing to the maintenance of NSs integrity.
From our results, we have provided new insights as to how
biological constraints such as host alternation are necessary to
maintain RVFV integrity and virulence. Contrary to most other
arboviruses, RVFV could escape from the alternating host
replication cycle to evolve more rapidly, like single-host animal
RNA viruses. Thus, our single-host adapted RVFV present large
deletions in the NSs gene associated with a loss of virulence when
inoculated into mice, which develop a long-lasting immunity. In
contrast to persistent non-cytolytic replication in insects, arbovi-
ruses must replicate to high titers in the mammalian host. This
increases the probability of transmission during a blood-meal
[37,38]. By its transfer from wild animals (e.g. buffalo [39]) to
livestock, RVFV may intensify direct transmission by contacts with
infectious tissues or fluids hosting high viral loads. From our
results, viruses selected on mammalian cells may favor attenuation
via NSs alteration, leading to the maintenance of avirulent RVFV
strains. Surprisingly, mosquito cell-specific selection also leads to
large deletions in the NSs gene, with similar phenotypic
consequences. In both cases, virulence will only be restored when
alternation between both cell types is initiated in conditions that
would reconstitute a complete viral genome by reassortments with
a virulent RVFV strain. Such in vitro studies should be consolidated
with studies using in vivo systems. Indeed, vertebrates are subjected
to acute infections, with clearance of the virus being triggered by
the immune defense system, whereas insect vectors sustain
persistent viral replication and are the site of such genetic changes
as reassortment or recombination upon co-infection [40]. Such
rearrangements may restore virulence, upon the acquisition of a
complete NSs gene in the course of virus replication [41]. Finally,
our results suggest that subtle modifications of selective filters can
lead to major genetic changes within a viral population.
Supporting Information
Figure S1 Replication kinetics of the parental P strain
performed at two MOI (0.1 and 0.01). The parental P strain
was used to infect BHK21 cells (A) and Aag2 cells (B) at two MOI
(0.1 and 0.01). Supernatants were harvested at different hours
post-infection. Titers in PFU/mL were estimated by serial 10-fold
dilutions on Vero cells.
(PDF)
Figure S2 Phylogenetic analysis of complete nucleotide
sequence of the segments M and L. The complete M and L
segments of the parental P strain and the selected strains (Z30Alt,
Z30B and Z30A) were analyzed using the ML technique with
1,000 replicate bootstrap values (MEGA version 4), with
previously described RVFV strains from the different genetic
lineages (A to G) [27].
(PDF)
Table S1 Primers used for RT-PCR and sequencing.
(PDF)
Table S2 RVFV-specific antibodies (IgG) detected at
day 21 post-inoculation in mice. Mice were inoculated with
10
4 PFU of a RVFV strain. At day 21 post-inoculation, blood
samples were tested for IgG detected by ELISA. Whole cell lysate
from RVFV infected Vero E6 cells or negative control cell lysate
from uninfected Vero E6 cells were diluted in PBS and allowed to
absorb onto 96 well plates at +4uC overnight. They were used at
1:1000. Plates were incubated with blood samples diluted at 1:100
in 2% skim milk and 0.05% tween 20 in 16 PBS at 37uC for
1 hour. Plates were washed 4 times in PBST (16PBS with 0.05%
tween 20) and then incubated with goat anti-mouse (1:1000)
coupled with peroxydase for 1 hour at 37uC. Plates were washed 4
times in PBST prior to the addition of TMB substrate used
according to the manufacturer’s instructions. Reactions were
stopped after 10 min with the addition of 100 mL of phosphoric
acid H3PO4 (1:8) and read at 450–620 nm. All samples were run
in duplicate and averages were used in the analysis. Absolute
values obtained from negative control lysates were subtracted from
values obtained from the experimental antigen prior to analysis to
control for non-specific binding. D, control DMEM; Z30B, the
30
th serial passage in BHK21 cells; Z30A, the 30
th serial passage in
Aag2 cells; Z30BC, a clone selected from the 30
th serial passage in
BHK21 cells; Z30AC, a clone selected from the 30
th serial passage
in Aag2 cells; Z30Alt, the 30
th alternating passage in BHK21 and
Aag2 cells.
(PDF)
Table S3 RVFV-specific antibodies (IgG) in mice infect-
ed with Z30AC or Z30BC and challenged with P strain.
Two batches of 12 mice received a first dose of 10
4 PFU of Z30AC
or Z30BC, and inoculated 14 days later with 10
4 PFU of the
parental P strain for one half and the other half with DMEM.
RVFV-specific antibodies (IgG) were then detected by ELISA in
blood samples. Whole cell lysate from RVFV infected Vero E6
cells or negative control cell lysate from uninfected Vero E6 cells
were diluted in PBS and allowed to absorb onto 96 well plates at
+4uC overnight. They were used at 1:1000. Plates were incubated
with blood samples diluted at 1:100 in 2% skim milk and 0.05%
tween 20 in 16 PBS at 37uC for 1 hour. Plates were washed 4
times in PBST (16PBS with 0.05% tween 20) and then incubated
with goat anti-mouse (1:1000) coupled with peroxydase for 1 hour
at 37uC. Plates were washed 4 times in PBST prior to the addition
of TMB substrate used according to the manufacturer’s instruc-
tions. Reactions were stopped after 10 min with the addition of
100 mL of phosphoric acid H3PO4 (1:8) and read at 450–620 nm.
All samples were run in duplicate and averages were used in the
analysis. Absolute values obtained from negative control lysates
were subtracted from values obtained from the experimental
antigen prior to analysis to control for non-specific binding. D,
control DMEM; Z30BC, a clone selected from the 30
th serial
passage in BHK21 cells; Z30AC, a clone selected from the 30
th
serial passage in Aag2 cells; P, the parental strain.
(PDF)
Table S4 Nucleotide and amino-acid changes (in paren-
theses) observed in the three segments S, M and L.
Changes were recorded in the parental P strain and the selected
strains (Z30Alt, Z30B and Z30A) in reference to the strain ZH548.
(PDF)
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